2m 2m 2m 2m 2m 2m 2m
REPLIMUNE GRP (REPL)
NASDAQ
$10.00+$0.07 (+0.66%)
Price as of Jul 13, 2026 7:58 PM EDT- $922.6MMarket Cap
- -11.92%1-Year Change
- BiotechnologyIndustry
REPLIMUNE GRP (REPL)
$10.00+$0.07 (+0.66%)
Annual
Quarterly
03/31/2026 | 03/31/2025 | 03/31/2024 | 03/31/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | 98.7M N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -221.2M +16.75% | -189.4M +8.28% | -175.0M +38.28% | -126.5M +59.06% | |
Depreciation and Amortization Expense | 3.3M -4.85% | 3.5M +31.90% | 2.7M +8.50% | 2.4M +13.97% | |
Total Operating Expenses | 319.9M +22.28% | 261.6M +11.44% | 234.8M +32.58% | 177.1M +49.67% | |
Operating Profit | -319.9M +22.28% | -261.6M +11.44% | -234.8M +32.58% | -177.1M +49.67% | |
Interest Income | 13.6M -35.49% | 21.1M -9.57% | 23.4M +133.42% | 10.0M +2,465.64% | |
Interest Expense | -6.8M +17.68% | -5.8M +28.42% | -4.5M +129.09% | -2.0M N/A | |
Interest Income and Expense and Net | 6.8M -55.50% | 15.3M -18.63% | 18.9M +134.48% | 8.0M +1,962.31% | |
Total Nonoperating Income and Expense | 5.4M -63.32% | 14.8M -23.67% | 19.4M +528.63% | 3.1M +1,009.35% | |
Income before Taxes | -314.5M +27.41% | -246.8M +14.60% | -215.4M +23.79% | -174.0M +47.41% | |
Income Taxes | -551,000 -217.74% | 468,000 +14.71% | 408,000 +41.67% | 288,000 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -313.9M +26.95% | -247.3M +14.60% | -215.8M +23.82% | -174.3M +47.65% | |
Net Income from Continuing Operations Applicable to Common | -313.9M +26.95% | -247.3M +14.60% | -215.8M +23.82% | -174.3M +47.65% | |
Basic EPS and Net Income | -3.38 +10.10% | -3.07 -5.25% | -3.24 +8.36% | -2.99 +32.30% | |
Diluted EPS and Net Income | -3.38 +10.10% | -3.07 -5.25% | -3.24 +8.36% | -2.99 +32.30% | |
Basic Weighted Average Shares | 92.8M +15.19% | 80.6M +21.02% | 66.6M +14.36% | 58.2M +11.49% | |
Diluted Weighted Average Shares | 92.8M +15.19% | 80.6M +21.02% | 66.6M +14.36% | 58.2M +11.49% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 209.0M +88.11% | 111.1M +49.24% | 74.5M -49.21% | 146.6M +38.36% | |
Short-Term Investments | 59.9M -83.94% | 372.7M +7.65% | 346.2M -20.74% | 436.8M +50.77% | |
Cash and Cash Equivalents and Short-Term Investments | 268.9M -44.42% | 483.8M +15.01% | 420.7M -27.89% | 583.4M +47.45% | |
Total Current Assets | 279.1M -43.71% | 495.9M +14.35% | 433.7M -26.82% | 592.6M +46.69% | |
Accumulated Depreciation | 16.7M +24.87% | 13.4M +35.38% | 9.9M +36.66% | 7.2M +51.03% | |
Property and Plant and Equipment and Net | 13.0M -5.57% | 13.7M +31.06% | 10.5M +40.17% | 7.5M -5.72% | |
Total Long-Term Assets | 2.9M +145.17% | 1.2M -88.55% | 10.5M +40.17% | 7.5M -5.72% | |
Total Assets | 332.4M -39.71% | 551.3M +13.04% | 487.7M -24.57% | 646.6M +40.20% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 58.2M -6.63% | 62.4M +54.22% | 40.4M +19.55% | 33.8M +62.96% | |
Total Long-Term Debt | 83.3M +79.63% | 46.4M +3.50% | 44.8M +56.41% | 28.6M N/A | |
Total Long-Term Liabilities | 455,000 -51.65% | 941,000 +19.72% | 786,000 +66.53% | 472,000 -90.17% | |
Total Liabilities | 166.2M +22.69% | 135.5M +19.67% | 113.2M +24.00% | 91.3M +82.73% | |
Retained Earnings | -1.3B +33.10% | -948.6M +35.26% | -701.3M +44.45% | -485.5M +56.00% | |
Total Stockholders Equity | 166.2M -60.04% | 415.8M +11.04% | 374.5M -32.56% | 555.3M +35.03% | |
Total Shares Outstanding | 82.7M +7.31% | 77.1M +25.51% | 61.4M +8.36% | 56.7M +19.73% | |
Cash Flow | |||||
Cash from Operating Activities | -280.3M +45.82% | -192.3M +3.66% | -185.5M +44.84% | -128.1M +55.82% | |
Capital Expenditures | 4.2M -36.85% | 6.7M +18.10% | 5.7M +149.43% | 2.3M -2.83% | |
Cash from Investing Activities | 310.8M +1,406.28% | -23.8M -124.48% | 97.2M +168.21% | -142.5M +7,790.48% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 66.3M -73.73% | 252.4M +1,450.06% | 16.3M -94.77% | 311.3M +4,618.14% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -71.05% +49.26% | -47.60% +25.11% | -38.05% +20.92% | -31.47% +33.86% | |
Return on Equity | -107.88% +72.39% | -62.58% +34.82% | -46.42% +28.71% | -36.06% +39.01% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 4.79 -39.72% | 7.95 -25.85% | 10.72 -38.79% | 17.52 -9.99% | |
Cash Ratio | 3.59 +101.47% | 1.78 -3.23% | 1.84 -57.51% | 4.33 -15.10% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow